Supplementary Information
E. coli BL21 (DE3) containing AhQnr:pET-26b was grown in LB media supplemented with 50 μg/ml kanamycin until the optical density at 600 nm reached approximately 0. 5 Daventry, UK) and centrifugation (15 000 g, 25 minutes). The cleared lysate was applied to a 30 ml Q-sepharose FF column (GE Healthcare), the column was washed with buffer A until the absorbance at 280 nm returned to baseline and bound proteins eluted with a 1 L 0 -1 M NaCl gradient. Fractions containing AhQnr were identified by SDS-PAGE, pooled and dialysed overnight against Buffer A. After centrifugation (15 000 g, 25 minutes) the dialysate was applied to a 50 ml heparin-sepharose column (GE Healthcare) and bound proteins eluted on a 500 ml 0 -0.3 M NaCl gradient. This step was omitted for material used to produce the orthorhombic crystal form. Fractions containing AhQnr were pooled, concentrated by centrifugation (Amicon Ultra-15) to be further purified by size exclusion chromatography on a 350 ml Superdex S-75 column (GE Healthcare) in Buffer B (20 mM Tris-HCl pH 8.0, 1M NaCl, 5mM -mercaptoethanol, 5% glycerol; protein for crystallization, biophysical and activity assays) or a 350 ml Superdex S-200 HR column (GE Healthcare) in Buffer C (20 mM HEPES pH 8.0, 1 M NaCl, 5% glycerol; protein for reductive methylation).
Selenomethionine-substituted AhQnr was expressed in E. coli B834 (DE3) (Novagen) harbouring plasmid AhQnr:pET-26b, grown in SelenoMethionine Expression Media (Molecular Dimensions) following the manufacturer's protocol. Briefly, a 100 ml bacterial culture was grown overnight at 37 o C in LB broth, cells were pelleted by centrifugation (20 minutes, 4 000 g) , washed 3 times in 100 ml of sterile water, resuspended in 1 ml of water and innoculated into 1 L of prewarmed (30 o C) SelenoMethionine Expression Media containing L-SeMet. Cells were grown for 2 h before the addition of IPTG to 1 mM and growth was continued for a further 6 hours prior to cell harvest. Expressed protein was purified as described above.
Crystallisation
Wild-type AhQnr dialyzed into Buffer E (20 mM phosphate pH 8.0, 100 mM KCl, 5% glycerol, 20 mM DTT) and concentrated to 10 mg/ml crystallized from 0.1 M sodium cacodylate pH 6.8, (monoclinic crystal form, native data set) and I02 (SeMet data set) of the U.K. Diamond Light Source. For the Se-Met data set the wavelength for data collection with maximal anomalous scattering (i.e. maximal f'') was selected based on analysis of an X-ray fluorescence scan of a mounted crystal using the program CHOOCH (4) . Diffraction data were indexed and scaled using the programs MOSFLM (5) and SCALA (6) . Data processing statistics are given in Table 1 .
The AhQnr structure was solved by single-wavelength anomalous diffraction (SAD; (7)) using data collected from a single crystal of the Se-Met protein. Automated Patterson searches using SOLVE (8) as implemented in PHENIX (9), readily located four Se sites in the monoclinic asymmetric unit. Electron density maps calculated using these initial phases at 3.0 Å resolution were, after solvent flattening and density modification in RESOLVE (10), sufficient to enable a partial polyserine model, comprising 4 pentapeptide repeat coils originally derived from the MfpA structure (11), to be placed for one of the two subunits present in the asymmetric unit using MOLREP (12) , as implemented in the CCP4 suite (13) .
Application of NCS (non-crystallographic symmetry) operators derived from the Se positions, together with multiple rounds of manual (Coot; (14) ) and automated (RESOLVE) rebuilding and phase extension against the 2.0 Å native data set, permitted us to construct an improved model comprising 235 of the total 432 residues of the AhQnr dimer. At this point re-running RESOLVE, starting from the original SOLVE phases, imposing NCS operators derived from this model and including the 2.0 Å native data set, resulted in dramatically improved electron density maps. Subsequent rounds of manual rebuilding in Coot with addition of water using ARP (15) and refinement with REFMAC5 (16) proceeded smoothly. The resulting structure, after removal of the projecting loops 1 and 2, was then used to solve that of the orthorhombic crystal form by molecular replacement using Phaser (17) . Refinement statistics for the two structures are given in Table 1 .
Generation and Production of AhQnr Mutants
Mutants were constructed in a hexahistidine-tagged variant of AhQnr, AhQnr-6His, in order to facilitate protein purification. AhQnr-6His was generated by using primers AhQnrFwd and AhQnrRevNoStop (Table S1) Deletion mutants of AhQnr were constructed on the AhQnr-6His:pET-26b template using the QuikChange II mutagenesis kit (Agilent) according to the manufacturer's instructions with primers as specified (Table S1 ). Amplifications were performed for 1' at 95°C followed by 25 cycles of 1' 95°C, 2' 55°C, 8' 68°C. The double deletion mutant (double) was constructed in a second round of mutagenesis where loop1 was deleted from loop2. The presence of the expected mutations was confirmed by complete sequencing in both directions of the AhQnr open reading frame. AhQnr-6His and loop2 were expressed as described for wild-type AhQnr (above). loop1 and double were expressed in E. coli ArcticExpress (DE3) (Agilent) induced with 1 mM IPTG at an OD600 of 0.5 for 48 hours at 12 °C.
AhQnr-6His and mutant proteins were purified by two column chromatography steps carried out at 4 o C. Clarified cell lysates were prepared as above in Buffer G (40 mM phosphate pH 8.0, 20 mM imidazole, 300 mM NaCl, 10% glycerol), applied to a 5 ml Ni-NTA Superflow column (Qiagen, Crawley, UK) and recirculated for at least 1 hour. The column was washed extensively in Buffer G and bound proteins eluted on a step gradient using 50 ml washes in Buffer G containing increasing concentrations of imidazole (50 mM, 100 mM, 250 mM, 500 mM). Eluted wild-type and loop2 proteins were concentrated by centrifugation and further purified on a 350 ml Superdex S-200 HR column equilibrated in Buffer H (25 mM Tris-HCl pH 7.5, 2 mM DTT, 5% glycerol). Both the loop1 and double mutants precipitated in Buffer G in the presence of salts (NaCl and imidazole); these precipitates were collected by centrifugation and resolubilised in Buffer H prior to size exclusion chromatography. Predicted solubility (blue; calculated according to (19) ); and charge at pH 7.0 (green) and pI (cyan) (calculated using the program Protean (DNASTAR, Inc.)) for Qnr family members from Gram-negative bacteria. Tables   Table S1: 
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